◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › T › TNXP

Tonix Pharmaceuticals Holding Corp. (TNXP) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-11-02

Tonix Pharmaceuticals Holding Corp. (TNXP) operates in the Biotechnology industry and is headquartered in Berkeley Heights, United States with about 142 employees. Its market capitalization is roughly $87 million. In the fiscal year ended 2025-12-31, TNXP reported $13M in revenue and ($124M) in net income.

Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States.

Interactive charts & full statements → Open the TNXP valuation workbench →

TNXP Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$29M$13M$10M$8M$0M—
Gross Profit$24M$6M$2M$3M$0M—
Operating Income (EBIT)($165M)($126M)($137M)($118M)($112M)—
Net Income($160M)($124M)($130M)($117M)($110M)—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TNXP Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-31
Total Revenue$14M$7M$5M$3M$2M—
Gross Profit$13M$5M$4M$2M($1M)—
Operating Income (EBIT)($42M)($42M)($48M)($33M)($28M)—
Net Income($41M)($40M)($47M)($32M)($28M)—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TNXP Free Cash Flow History

TNXP Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$277M$163M$154M$226M—
Total Liabilities$32M$23M$49M$18M—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TNXP viewer.

Other Companies in Biotechnology

← TNXAll “T” companiesTNXT →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.